$BGLC
BioNexus Gene Lab Corp
Nasdaq · Healthcare · Services-Medical Laboratories · Kuala Lumpur
BGLC chart
What traders are saying about $BGLC
Latest postsBioNexus Gene Lab Corp news
- BioNexus Gene Lab Corp Estimates – NASDAQ:BGLC
TradingView ·
- Four parties report ownership of the same BioNexus Gene Lab (BGLC) shares.
Stock Titan ·
- BioNexus to Build AI Applications for Malaysian Healthcare Under Exclusive CogniAI Licence
Yahoo Finance ·
- RYET to Enter Malaysian Healthcare Through Exclusive Cogni AI License to BioNexus Gene Lab
Yahoo Finance ·
- BioNexus Advances VitaGuard™ Southeast Asia Rollout Following China Working Visit
Yahoo Finance ·
- BioNexus Gene Lab Corp. Calls for Malaysia–China Biotechnology Cooperation to Move Beyond Trade into Co-Development
Yahoo Finance ·
- BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard™ MRD Platform
Yahoo Finance ·
- BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman
Yahoo Finance ·
- BioNexus Launches Regional Deployment of VitaGuard™ MRD Infrastructure; Positioned to Challenge Legacy Oncology Platforms Across ASEAN’s Multi-Billion Dollar Market
Yahoo Finance ·
- BioNexus Gene Lab Corp. (Nasdaq: BGLC) and Fidelion Diagnostics Execute Exclusive Southeast Asia License for VitaGuard™ MRD Platform as Part of Strategic Alliance with Tongshu Gene
Yahoo Finance ·
- BioNexus Gene Lab Corp. (Nasdaq: BGLC) Announces Strategic Agreements with Fidelion Diagnostics for Southeast Asia MRD Commercialization
Yahoo Finance ·
BioNexus Gene Lab Corp key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $7.4M | $9.5M | $9.8M | $10.9M |
| Net income | -$3.0M | -$1.6M | -$2.6M | -$355,966 |
| Diluted EPS | – | $-0.09 | $-0.17 | – |
| Total assets (year end) | $9.3M | $10.4M | $11.4M | $8.7M |
| Cash and equivalents (year end) | $2.4M | $2.9M | – | – |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About BioNexus Gene Lab Corp
- Ticker
- BGLC (Nasdaq)
- Industry
- Services-Medical Laboratories
- Headquarters
- Kuala Lumpur
- Incorporated in
- WY
- Fiscal year end
- December 31
- SEC CIK
- 1737523
- Former names
- BioNexus Gene Lab Coporation
Frequently asked questions
What exchange is BioNexus Gene Lab Corp listed on?
BioNexus Gene Lab Corp trades on the Nasdaq under the ticker symbol BGLC.
What industry is BioNexus Gene Lab Corp in?
BioNexus Gene Lab Corp is classified by the SEC under "Services-Medical Laboratories", part of the Healthcare sector on StockTweeting.
Where is BioNexus Gene Lab Corp headquartered?
BioNexus Gene Lab Corp's business address on file with the SEC is in Kuala Lumpur.
When does BioNexus Gene Lab Corp's fiscal year end?
BioNexus Gene Lab Corp's fiscal year ends on December 31.
How much revenue did BioNexus Gene Lab Corp report?
BioNexus Gene Lab Corp reported $7.4M in revenue for calendar year 2025, according to its SEC filings.